Extended amantadine-induced livedo reticularis

Rev Neurol (Paris). 2021 Dec;177(10):1301-1303. doi: 10.1016/j.neurol.2021.02.395. Epub 2021 Jul 3.

Authors

R Vollhardt¹, C Budowski¹, P Manceau¹, M Mongin¹, B Degos²

Affiliations

¹ Service de neurologie, AP-HP, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France.
² Service de neurologie, AP-HP, hôpital Avicenne, université Sorbonne Paris Nord, Bobigny, France; Dynamics and pathophysiology of neuronal networks team, center for interdisciplinary research in biology, Collège de France, CNRS UMR7241, INSERM U1050, université PSL, 75005 Paris, France. Electronic address: bertrand.degos@aphp.fr.

PMID: 34229870
DOI: 10.1016/j.neurol.2021.02.395

No abstract available

Publication types

Letter

MeSH terms

Amantadine / adverse effects
Humans
Livedo Reticularis* / chemically induced
Livedo Reticularis* / diagnosis
Parkinson Disease* / drug therapy

Substances

Amantadine